Neuroone Medical Technologies (NMTC) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00% |
| Dec 31, 2025 | -10.35% |
| Sep 30, 2025 | -50.01% |
| Jun 30, 2025 | -3.66% |
| Mar 31, 2025 | 46.24% |
| Dec 31, 2024 | 16.76% |
| Sep 30, 2024 | -18.47% |
| Jun 30, 2024 | -7.08% |
| Jun 30, 2023 | -9.20% |
| Mar 31, 2023 | -43.13% |
| Dec 31, 2022 | -42.31% |
| Sep 30, 2022 | 29.95% |
| Jun 30, 2022 | -36.21% |
| Mar 31, 2022 | -55.80% |
| Dec 31, 2021 | -72.43% |
| Sep 30, 2021 | -201.51% |
| Jun 30, 2021 | -208.37% |
| Dec 31, 2020 | -212.86% |
| Sep 30, 2020 | 143.62% |
| Jun 30, 2020 | -311.85% |
| Mar 31, 2020 | -129.61% |
| Jun 30, 2019 | -522.10% |
| Jun 30, 2018 | -163.89% |
| Mar 31, 2018 | -187.98% |
| Dec 31, 2017 | -237.48% |
| Sep 30, 2017 | -165.04% |
| Jun 30, 2017 | -200.73% |
| Mar 31, 2017 | -129.44% |
| Dec 31, 2016 | -62.62% |
| Sep 30, 2016 | 31.88% |
| Jun 30, 2016 | -47.35% |
| Dec 31, 2015 | -63.30% |
| Sep 30, 2015 | 7.35% |